Galecto

Copenhagen, Denmark

Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.

Feb 2026

Post-IPO Equity

Top Investors

Andreessen HorowitzRA Capital ManagementWellington ManagementJanus Henderson InvestorsBalyasny Asset Management

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Galecto's investors?

Galecto's investors include Andreessen Horowitz, RA Capital Management, Wellington Management, Janus Henderson Investors, Balyasny Asset Management.

Where is Galecto headquartered?

Galecto is headquartered in Copenhagen, Denmark.

What does Galecto do?

Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.

What stage is Galecto at?

Galecto is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 10, 2026.

MLA

"Galecto — Funding & Investors." VCBacked, February 10, 2026, https://www.vcbacked.co/company/galecto. Accessed July 1, 2026.

APA

VCBacked. (2026). Galecto — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/galecto

Wikipedia (cite web)

{{cite web |title=Galecto — Funding & Investors |url=https://www.vcbacked.co/company/galecto |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 10, 2026.